CAMBRIDGE (CBS) — Moderna says its vaccine is 96% effective in protecting kids between 12 and 17 years old against COVID-19. That data is from a study of more than 3,2000 participants who received at least one dose of the vaccine.
The Cambridge-based biotech company also said none of the participants had severe reactions to the first or to the second shot.READ MORE: Joliet Man Loses All His Bitcoin After Fraudster Hijacks His Phone Number Hacks His Accounts
“No serious safety concerns have been identified to date,” Moderna said about the trial on teens.READ MORE: 17-Year-Old Charged In Carjacking Of Rideshare Driver In Beverly
Moderna said another study of the vaccine on children 6 months to 11 years old is ongoing but didn’t give further details.MORE NEWS: Banking History Going On Display As New Centier Bank Museum Is Set To Open In Whiting, Indiana
Earlier this week Moderna, which is expanding its manufacturing plant and lab in Norwood, said a third vaccine booster dose it developed shows it works against the more contagious South African and Brazilian variants.